WHO/ISUP classification, grading and pathological staging of renal cell carcinoma: standards and controversies
Tóm tắt
Từ khóa
Tài liệu tham khảo
International Agency for Research on Cancer (2016) WHO classification of tumours of the urinary system and male genital organs (IARC WHO classification of tumours), 4th edn. WHO/IARC Press, Lyon
Algaba F, Delahunt B, Berney DM, Camparo P, Compérat E, Griffiths D et al (2012) Handling and reporting of nephrectomy specimens for adult renal tumours: a survey by the European Network of Uropathology. J Clin Pathol 65:106–113
Delahunt B, Srigley JR, Montironi R, Egevad L (2014) Advances in renal neoplasia: recommendations from the 2012 International Society of Urological Pathology Consensus Conference. Urology 83:969–974
Delahunt B, Egevad L, Montironi R, Srigley JR (2013) International Society of Urological Pathology (ISUP) consensus conference on renal neoplasia: rationale and organization. Am J Surg Pathol 37:1463–1468
Delahunt B, Cheville JC, Martignoni G, Humphrey PA, Magi-Galluzzi C, McKenney J et al (2013) The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am J Surg Pathol 37:1490–1504
Srigley JR, Delahunt B, Eble JN, Egevad L, Epstein JI, Grignon D et al (2013) The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia. Am J Surg Pathol 37:1469–1489
Tan PH, Cheng L, Rioux-Leclercq N, Merino MJ, Netto G, Reuter VE et al (2013) Renal tumors: diagnostic and prognostic biomarkers. Am J Surg Pathol 37:1518–1531
Trpkov K, Grignon DJ, Bonsib SM, Amin MB, Billis A, Lopez-Beltran A et al (2013) Handling and staging of renal cell carcinoma: the International Society of Urological Pathology Consensus (ISUP) conference recommendations. Am J Surg Pathol 37:1505–1517
Reuter VE, Argani P, Zhou M, Delahunt B, Members of the ISUP Immunohistochemistry in Diagnostic Urologic Pathology Group (2014) Best practices recommendations in the application of immunohistochemistry in the kidney tumors: report from the International Society of Urologic Pathology consensus conference. Am J Surg Pathol 38:e35–e49
Amin MB, Epstein JI, Ulbright TM, Humphrey PA, Egevad L, Montironi R et al (2014) Best practices recommendations in the application of immunohistochemistry in urologic pathology: report from the International Society of Urological Pathology consensus conference. Am J Surg Pathol 38:1017–1022
Delahunt B, Srigley J, Amin M, Billis A, Camparo P, Evans A et al (2017) Invasive carcinoma of renal tubular origin, histopathology reporting guide, 1st edn. International Collaboration on Cancer Reporting, Sydney
Delahunt B, Srigley J, Amin M, Billis A, Camparo P, Evans A et al (2017) Renal biopsy for tumour, histopathology reporting guide, 1st edn. International Collaboration on Cancer Reporting, Sydney
Warren AY, Griffiths D, Fleming S (2017) Dataset for histopathological reporting of adult renal parenchyma neoplasms, 3rd edn. The Royal College of Pathologists, London
Moch H, Gasser T, Amin MB, Torhorst J, Sauter G, Mihatsch MJ (2000) Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors. Cancer 89:604–614
Ljungberg B, Alamdari FI, Stenling R, Roos G (1999) Prognostic significance of the Heidelberg classification of renal cell carcinoma. Eur Urol 36:565–569
Murphy WM, Grignon DJ, Perlman EJ (2004) Tumours of the kidney, bladder and related urinary structures, vol 4. AFIP atlas of tumour pathology. American Registry of Pathology, Washington
Kim H, Cho NH, Kim DS, Kwon YM, Kim EK, Rha SH et al (2004) Renal cell carcinoma in South Korea: a multicenter study. Hum Pathol 35:1556–1563
Srigley JR, Delahunt B (2009) Uncommon and recently described renal carcinomas. Mod Pathol 22:S2–S23
Novara G, Ficarra V, Antonelli A, Artibani W, Bertini R, Carini M et al (2010) Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: are further improvements needed? Eur Urol 58:588–595
Leibovich BC, Lohse CM, Crispen PL, Boorjian SA, Thompson RH, Blute ML et al (2010) Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma. J Urol 183:1309–1315
O’Brien MF, Russo P, Motzer RJ (2008) Sunitinib therapy in renal cell carcinoma. BJU Int 101:1339–1342
Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML (2003) Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 27:612–624
Steffens S, Roos FC, Janssen M, Becker F, Steinestel J, Abbas M et al (2014) Clinical behaviour of chromophobe renal cell carcinoma is less aggressive than that of clear cell renal cell carcinoma, independent of Fuhrman grade or tumor size. Virchows Arch 465:439–444
Amin MB, Amin MB, Tamboli P, Javidan J, Stricker H, de Venturina MP et al (2002) Prognostic impact of histologic subtypes of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol 26:281–291
Nickerson ML, Jaeger E, Shi Y, Durocher JA, Mahurkart S, Zaridze D et al (2008) Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumours. Clin Cancer Res 14:4726–4734
Maher ER (2018) Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management. World J Urol. https://doi.org/10.1007/s00345-018-2288-5 . [Epub ahead of print]
Taneja K, Arora S, Rogers CG, Gupta NS, Williamson SR (2018) Pathologic staging of renal cell carcinoma: a review of 300 consecutive cases with emphasis on retrograde venous invasion. Histopathology https://doi.org/10.1111/his.13672 . [Epub ahead of print]
Bhatt JR, Jewett MA, Richard PO, Kawaguchi S, Timilshina N, Evans A et al (2016) Multilocular cystic renal cell carcinoma: pathological T staging makes no difference to favourable outcomes and should be reclassified. J Urol 196(5):1350–1355
Delahunt B, Eble JN (1997) Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol 10:537–544
Adeniran AJ, Shuch B, Humphrey PA (2015) Hereditary renal cell carcinoma syndromes. Clinical, pathologic and genetic features. Am J Surg Pathol 39(12):e1–e18
Delahunt B, Eble JN, McCredie MR, Bethwaite PB, Stewart JH, Bilous AM (2001) Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases. Hum Pathol 32:590–595
Cancer Genome Atlas Research Network, Linehan WM, Spellman PT, Ricketts CJ, Creighton CJ et al (2016) Comprehensive molecular characterisation of papillary renal cell carcinomas. N Engl J Med 374(2):135–145
Flippot R, Comperat E, Tannir NM, Maloaf GG (2018) Papillary renal cell carcinoma: a family portrait. Eur Urol 73:79–80
Saleeb RM, Brimo F, Farag M, Rompré-Brodeur A, Rotondo F, Beharry V (2017) Toward biological subtyping of papillary renal cell carcinoma with clinical implications through histologic, immunohistochemical and molecular analysis. Am J Surg Pathol 41:1618–1629
Ren Q, Wang L, Al-Ahmadie HA, Fine SW, Gopalan A, Sirintrapun SJ et al (2018) Distinct genomic copy number alterations distinguish mucinous tubular and spindle cell carcinoma of the kidney from papillary renal cell carcinoma with overlapping histologic features. Am J Surg Pathol 42(6):767–777
Shuch B, Amin A, Armstrong AJ, Eble JN, Ficarra V, Lopez-Beltran A et al (2015) Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexity. Eur Urol 67:85–97
Tan MH, Wong CF, Tan HL, Yang XJ, Ditley J, Matsuda D et al (2010) Genomic expression and single nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma. BMC Cancer 10:196
Pavlovich CP, Walther MM, Eyler RA, Hewitt SM, Zbar B, Linehan WM et al (2002) Renal tumors in the Birt-Hogg-Dubé syndrome. Am J Surg Pathol 26:1542–1552
Ohe C, Smith SC, Sirohi D, Divatia M, de Peralta-Venturina M, Paner GP et al (2018) Reappraisal of morphologic differences between renal medullary carcinoma, collecting duct carcinoma and fumarate hydratase-deficient renal cell carcinoma. Am J Surg Pathol 42:279–292
Cutruzzula P, Cahn D, Kivlin D, Tong C, Edwards D, Amster M (2016) A review of translocation t(6;11) renal cell carcinoma tumours in the adult patient. Curr Urol 10:69–71
Zhou H, Zheng S, Truong LD, Ro JY, Ayala AG, Shen SS (2014) Clear cell papillary renal cell carcinoma is the fourth most common histological type of renal cell carcinomas in 290 consecutive nephrectomies for renal cell carcinoma. Hum Pathol 45:59–64
Przybycin CG, Harper HL, Reynolds JP, Magi-Galluzzi C, Nguyen JK, Wu A et al (2018) Acquired cystic disease-associated renal cell carcinoma (ACD-RCC): a multiinstitutional study of 40 cases with clinical follow-up. Am J Surg Pathol 42:1156–1165. https://doi.org/10.1097/pas.0000000000001091 [Epub ahead of print]
Amin MB, MacLennan GT, Gupta R, Grignon D, Paraf F, Vieillefond A et al (2009) Tubulocystic carcinoma of the kidney: clinicopathologic analysis of 31 cases of a distinctive rare subtype of renal cell carcinoma. Am J Surg Pathol 33:384–392
Tran T, Jones CL, Williamson SR, Eble JN, Grignon DJ, Zhang S et al (2016) Tubulocystic renal cell carcinoma is an entity that is immunohistochemically and genetically distinct from papillary renal cell carcinoma. Histopathology 68:850–857
Zhang P, Yang X, Yu L, Wu Y, Wang C (2017) Tubulocystic renal cell carcinoma of the kidney: a clinical, pathological, immunohistochemical, and fluorescence in situ hybridization study. Int J Clin Exp Pathol 10(3):3327–3334
Lawrie CH, Armesto M, Fernandez-Mercado M, Arestin M, Manterola L, Goicoechea I (2018) Noncoding RNA expression and targeted next-generation sequencing distinguish tubulocystic renal cell carcinoma (TC-RCC) and other renal neoplasms. J Mol Diagn 20(1):34–45
Menko FH, Maher ER (2016) Diagnostic and management of hereditary renal cell cancer. Recent Results Cancer Res 205:85–104
Williamson SR, Eble JN, Amin MB, Gupta NS, Smith SC, Sholl LM et al (2015) Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterisation of 11 tumors defining a unique subtype of renal cell carcinoma. Mod Pathol 28:80–94
Chen Y-B, Brannon R, Toubaji A, Dudas ME, Won HH, Al-Ahmadie HA et al (2014) Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry. Am J Surg Pathol 38(5):627–637
Merino MJ, Torres-Cabala C, Pinto P, Lineman WM (2007) The morphological spectrum of kidney tumours in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome. Am J Surg Pathol 31:1578–1585
Grubb RL 3rd, Franks ME, Toro J, Middleton L, Choyke L, Fowler S et al (2007) Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer. J Urol 177:2074–2079
Trpkov K, Hes O, Agaimy A, Bonert M, Martinek P, Magi-Galluzzi C et al (2016) Fumarate hydratase-deficient renal cell carcinoma is strongly correlated with fumarate hydratase mutation and hereditary leiomyomatosis and renal cell carcinoma syndrome. Am J Surg Pathol 40(7):865–875
Smith SC, Trpkov K, Chen Y-B, Mehra R, Sirohi D, Ohe C et al (2016) Tubulocystic carcinoma of the kidney with poorly differentiated foci: a frequent morphological pattern of fumarate hydratase-deficient renal cell carcinoma. Am J Surg Pathol 40(11):1457–1472
Guo J, Tretiakova MS, Troxwell ML, Osunkoya AO, Fadare O, Sangoi AR et al (2014) Tuberous sclerosis-associated renal cell carcinoma. A clinicopathological study of 57 separate carcinomas in 18 patients. Am J Surg Pathol 38(11):1457–1467
Yang P, Cornejo KM, Sadow PM, Cheng L, Wang M, Xiao Y et al (2014) Renal cell carcinoma in tuberous sclerosis complex. Am J Surg Pathol 38:895–909
Trpkov K, Hes O, Bonert M, Lopez JI, Bonsib SM, Nesi G et al (2016) Eosinophilic solid and cystic renal cell carcinoma. Clinicopathological study of 16 unique sporadic neoplasms occurring in women. Am J Surg Pathol 40(1):60–71
Trpkov K, Abou-Ouf H, Hes O, Lopez JI, Nesi G, Comperat E, Sibony M et al (2017) Eosinophilic solid and cystic renal cell carcinoma (ESC RCC). Further morphologic and molecular characterisation of ESC RCC as a distinct entity. Am J Surg Pathol 41(10):1299–1308
Li Y, Reuter VE, Matoso A, Netto GJ, Epstein JI, Argani P (2018) Re-evaluation of 33 ‘unclassified’ eosinophilic renal cell carcinomas in young patients. Histopathology 72:588–600
Palsgrove DN, Li Y, Pratilas C, Lin MT, Pallavajjalla A, Gocke C et al (2018) Eosinophilic solid and cystic (ESC) renal cell carcinomas harbour TSC mutations: molecular analysis supports an expanding clinicopathological spectrum. Am J Surg Pathol 42:1166–1181. https://doi.org/10.1097/pas.0000000000001111 [Epub ahead of print]
Parilla M, Kadri S, Patil SA, Ritterhouse L, Segal J, Henriksen KJ et al (2018) Are sporadic eosinophilic solid and cystic renal cell carcinomas characterised by somatic tuberous sclerosis gene mutations? Am J Surg Pathol 42(7):911–917
Perrino CM, Grignon DJ, Williamson SR, Idrees MT, Eble JN, Cheng L (2018) Morphological spectrum of renal cell carcinoma, unclassified: an analysis of 136 cases. Histopathology 72(2):305–319
Kryvenko ON, Jorda M, Argani P, Epstein J (2014) Diagnostic approach to eosinophilic renal neoplasms. Arch Pathol Lab Med 138(11):1531–1541
Williamson SR, Gadde R, Trpkov K, Hirsch MS, Srigley JR, Reuter VE et al (2017) Diagnostic criteria for oncocytic renal neoplasms: a survey of urologic pathologists. Hum Pathol 63:149–156
Fuhrman SA, Lasky LC, Limas C (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6:655–663
Sika-Paotonu D, Bethwaite PB, McCredie MR, William Jordan T, Delahunt B (2006) Nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma. Am J Surg Pathol 30:1091–1096
Delahunt B (2009) Advances and controversies in grading and staging of renal cell carcinoma. Mod Pathol 22:S24–S36
Delahunt B, Sika-Paotonu D, Bethwaite PB, McCredie MR, Martignoni G, Eble JN et al (2007) Fuhrman grading is not appropriate for chromophobe renal cell carcinoma. Am J Surg Pathol 31:957–960
Delahunt B, Sika-Paotonu D, Bethwaite PB, William Jordan T, Magi-Galluzzi C, Zhou M et al (2011) Grading of clear cell renal cell carcinoma should be based on nucleolar prominence. Am J Surg Pathol 35:1134–1139
Finley DS, Shuch B, Said JW, Galliano G, Jeffries RA, Afifi AA et al (2011) The chromophobe tumor grading system is the preferred grading scheme for chromophobe renal cell carcinoma. J Urol 186:2168–2174
Paner GP, Amin MB, Alvarado-Cabrero I, Young AN, Stricker HJ, Moch H et al (2010) A novel tumor grading scheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Fuhrman nuclear grade. Am J Surg Pathol 34:1233–1240
Delahunt B, McKenney JK, Lohse CM, Leibovich BC, Thompson RH, Boorjian SA et al (2013) A novel grading system for clear cell renal cell carcinoma incorporating tumor necrosis. Am J Surg Pathol 37:311–322
Khor LY, Dhakal HP, Jia X, Reynolds JP, McKenney JK, Rini BI et al (2016) Tumor necrosis adds prognostically significant information to grade in clear cell renal cell carcinoma: a study of 842 consecutive cases from a single institution. Am J Surg Pathol 40:1224–1231
Verine J, Colin D, Nheb M, Prapotnich D, Ploussard G, Cathelineau X et al (2018) Architectural patterns are a relevant morphologic grading system for clear cell renal cell carcinoma prognosis assessment. Am J Surg Pathol 42(4):423–441
Leibovich BC, Blute ML, Cheville JC, Lohse CM, Frank I, Kwon ED et al (2003) Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer 97:1663–1671
Amtrup F, Hansen JB, Thybo E (1974) Prognosis in renal carcinoma evaluated from histological criteria. Scand J Urol Nephrol 8:198–202
Thompson RH, Cheville JC, Lohse CM, Webster WS, Zincke H, Kwon ED et al (2005) Reclassification of patients with pT3 and pT4 renal cell carcinoma improves prognostic accuracy. Cancer 104:53–60
Sengupta S, Lohse CM, Leibovich BC, Frank I, Thompson RH, Webster WS et al (2005) Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness. Cancer 104:511–520
Peckova K, Martinek P, Pivovarcikova K, Vanecek T, Alaghehbandan R, Prochazkova K et al (2017) Cystic and necrotic papillary renal cell carcinoma: prognosis, morphology, immunohistochemical and molecular-genetic profile of 10 cases. Ann Diagn Pathol 26:23–30
Peckova K, Vanecek T, Martinek P, Spangnolo D, Kurdoda N, Brunelli M et al (2014) Aggressive and nonaggressive translocation t(6;11) renal cell carcinoma: comparative study of 6 cases and review of the literature. Ann Diagn Pathol 18:351–357
Collins J, Epstein JI (2017) Prognostic significance of extensive necrosis in renal cell carcinoma. Hum Pathol 66:108–114
Park JY, Lee JL, Baek S, Eo SH, Go H, Ro JY et al (2014) Sarcomatoid features, necrosis, and grade are prognostic factors in metastatic clear cell renal cell carcinoma with vascular endothelial growth factor-targeted therapy. Hum Pathol 45(7):1437–1444
Ficarra V, Novara G, Iafrate M, Cappellaro L, Bratti E, Zattoni F et al (2007) Proposal for reclassification of the TNM staging system in patients with locally advanced (pT3–4) renal cell carcinoma according to the cancer-related outcome. Eur Urol 51:722–729
Klatte T, Said JW, de Martino M, Larochelle J, Shuch B, Rao JY et al (2009) Presence of tumor necrosis is not a significant predictor of survival in clear cell renal cell carcinoma: higher prognostic accuracy of extent based rather than presence/absence classification. J Urol 181:1558–1564
Renshaw AA, Cheville JC (2015) Quantitative tumour necrosis is an independent predictor of overall survival in clear cell renal cell carcinoma. Pathology 47:34–37
Cheville JC, Lohse CM, Zincke H, Weaver AL, Leibovich BC, Frank I et al (2004) Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome. Am J Surg Pathol 28:435–441
Cangiano T, Liao J, Naitoh J, Dorey F, Figlin R, Belldegrun A (1999) Sarcomatoid renal cell carcinoma: biologic behavior, prognosis, and response to combined surgical resection and immunotherapy. J Clin Oncol 17:523–528
Delahunt B (1999) Sarcomatoid renal carcinoma: the final common dedifferentiation pathway of renal epithelial malignancies. Pathology 31:185–190
de Peralta-Venturina M, Moch H, Amin M, Tamboli P, Hailemariam S, Mihatsch M et al (2001) Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases. Am J Surg Pathol 25:275–284
Lebacle C, Pooli A, Bessede T, Irani J, Pantuck AJ, Drakaki A (2018) Epidemiology, biology and treatment of sarcomatoid RCC: current state of the art. World J Urol. https://doi.org/10.1007/s00345-018-2355
Zhang BY, Thompson RH, Lohse CM, Leibovich BC, Boorjian SA, Cheville JC et al (2015) A novel prognostic model for patients with sarcomatoid renal cell carcinoma. BJU Int 115:405–411
Adibi M, Thomas AZ, Borregales LD, Merrill MM, Slack RS, Chen HC et al (2015) Percentage of sarcomatoid component as a prognostic indicator for survival in renal cell carcinoma with sarcomatoid dedifferentiation. Urol Oncol 33:e17–e23
Kuroiwa K, Kinoshita Y, Shiratsuchi H, Oshiro Y, Tamiya S, Oda Y et al (2002) Renal cell carcinoma with rhabdoid features: an aggressive neoplasm. Histopathology 41:538–548
Gökden N, Nappi O, Swanson PE, Pfeifer JD, Vollmer RT, Wick MR et al (2000) Renal cell carcinoma with rhabdoid features. Am J Surg Pathol 24:1329–1338
Przybycin CG, McKenney JK, Reynolds JP, Campbell S, Zhou M, Karafa MT et al (2014) Rhabdoid differentiation is associated with aggressive behaviour in renal cell carcinoma: a clinicopathological analysis of 76 cases with clinical follow-up. Am J Surg Pathol 38(9):1260–1265
Leroy X, Zini L, Buob D, Ballereau C, Villers A, Aubert S (2007) Renal cell carcinoma with rhabdoid features: an aggressive neoplasm with overexpression of p53. Arch Pathol Lab Med 131:102–106
Agaimy A, Cheng L, Egevad L, Feyerabend B, Hes O, Keck B et al (2017) Rhabdoid and undifferentiated phenotype in renal cell carcinoma: analysis of 32 cases indicating a distinctive common pathway of dedifferentiation frequently associated with SWI/SNF complex deficiency. Am J Surg Pathol 41(2):253–262
Zhang BY, Cheville JC, Thompson RH, Lohse CM, Boojian SA, Leibovich BC et al (2015) Impact of rhabdoid differentiation on prognosis for patients with grade four renal cell carcinoma. Eur Urol 68:5–7
Bonsib SM (2008) Macroscopic assessment, dissection protocols and histologic sampling strategy for renal cell carcinomas. Diagn Histopathol 14:151–156
Sobin LH, Gospodarowicz MK, Wittekind C (2009) TNM classification of malignant tumours (UICC International Union Against Cancer), 7th edn. Wiley-Blackwell, Oxford
Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2011) AJCC cancer staging manual, 7th edn. Springer, New York
Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK et al (2016) AJCC cancer staging manual, 8th edn. Springer, New York
Brierley JD, Gospodarowicz MK, Wittekind C (2017) TNM classification of malignant tumours, 8th edn. Wiley-Blackwell, Hoboken
Delahunt B, Egevad L, Samaratunga H, Varma M, Verrill C, Cheville J et al (2017) UICC drops the ball in the 8th edition TNM staging of urological cancers. Histopathology 71:5–11
Paner GP, Stadler WM, Hansel DE, Montironi R, Lin DW, Amin MB (2018) Updates in the eighth edition of the tumor-node-metastasis staging classification for urologic cancers. Eur Urol 73(4):560–569
Delahunt B, Kittelson JM, McCredie MR, Reeve AE, Stewart JH, Bilous AM (2002) Prognostic importance of tumor size for localized conventional (clear cell) renal cell carcinoma: assessment of TNM T1 and T2 tumor categories and comparison with other prognostic parameters. Cancer 94:658–664
Bonsib SM (2005) T2 clear cell renal cell carcinoma is a rare entity: a study of 120 clear cell renal cell carcinomas. J Urol 174:1199–1202
Thomas DH, Verghese A, Kynaston HG, Griffiths DF (2003) Analysis of the prognostic implications of different tumour margin types in renal cell carcinoma. Histopathology 43:374–380
Bonsib SM, Gibson D, Mhoon M, Greene GF (2000) Renal sinus involvement in renal cell carcinomas. Am J Surg Pathol 24:451–458
Bonsib SM (2006) Renal lymphatics, and lymphatic involvement in sinus vein invasive (pT3b) clear cell renal cell carcinoma: a study of 40 cases. Mod Pathol 19:746–753
Bonsib SM (2007) Renal veins and venous extension in clear cell renal cell carcinoma. Mod Pathol 20:44–53
Thompson RH, Leibovich BC, Cheville JC, Webster WS, Lohse CM, Kwon ED et al (2005) Is renal sinus fat invasion the same as perinephric fat invasion for pT3a renal cell carcinoma? J Urol 174:1218–1221
Bailey GC, Boorjian SA, Ziegelmann MJ, Westerman ME, Lohse CM, Leibovich BC et al (2017) Urinary collecting system invasion is associated with poor survival in patients with clear-cell renal cell carcinoma. BJU Int 119:585–590
Chen L, Ma X, Li H, Li X, Gao Y, Zhang Y et al (2016) Invasion of the urinary collecting system is an independent prognostic factor in pT3 renal cell carcinoma. Urol Oncol 34:e11–e16
Verhoest G, Avakian R, Bensalah K, Thuret R, Ficarra V, Artibani W et al (2009) Urinary collecting system invasion is an independent prognostic factor of organ confined renal cell carcinoma. J Urol 182:854–859
Chen L, Li H, Gu L, Ma X, Li X, Zhang F et al (2016) Prognostic role of urinary collecting system invasion in renal cell carcinoma: a systematic review and meta-analysis. Sci Rep 6:21325
O’Malley RL, Godoy G, Kanofsky JA, Taneja SS (2009) The necessity of adrenalectomy at the time of radical nephrectomy: a systematic review. J Urol 181:2009–2017
Saitoh H, Nakayama M, Nakamura K, Satoh T (1982) Distant metastasis of renal adenocarcinoma in nephrectomized cases. J Urol 127:1092–1095
Madbouly K, Al-Qahtani SM, Ghazwani Y, Al-Shaibani S, Mansi MK (2007) Microvascular tumor invasion: prognostic significance in low-stage renal cell carcinoma. Urology 69:670–674
Lang H, Lindner V, Letourneux H, Martin M, Saussine C, Jacqmin D (2004) Prognostic value of microscopic venous invasion in renal cell carcinoma: long-term follow-up. Eur Urol 46:331–335
Griffiths DF, Verghese A, Golash A, Kynaston HG, Matthews PN, Hart AJ et al (2002) Contribution of grade, vascular invasion and age to outcome in clinically localized renal cell carcinoma. BJU Int 90:26–31
Kroeger N, Rampersaud EN, Patard JJ, Klatte T, Birkhäuser FD, Shariat SF et al (2012) Prognostic value of microvascular invasion in predicting the cancer specific survival and risk of metastatic disease in renal cell carcinoma: a multicenter investigation. J Urol 187:418–423
Karellas M, Jang T, Kagiwada M, Kinnaman M, Jarnagin W, Russo P (2009) Advanced-stage renal cell carcinoma treated by radical nephrectomy and adjacent organ or structure resection. BJU Int 103:160–164
Liu N, Wren J, Vertosick E, Lee J, Power N, Benfante N et al (2016) The prognostic impact of a positive vascular margin on pT3 clear cell renal cell carcinoma. J Urol 195:264–269
Antic T, Taxy JB (2015) Partial nephrectomy for renal tumors: lack of correlation between margin status and local recurrence. Am J Clin Pathol 143:645–651
Patel H, Johnson M, Pierorazio P, Sozio S, Sharma R, Iyoha E et al (2016) Diagnostic accuracy and risks of biopsy in the diagnosis of a renal mass suspicious for localized renal cell carcinoma: systematic review of the literature. J Urol 195:1340–1347
Jeon H, Seo S, Jeong B, Jeon S, Lee H, Choi H et al (2016) Percutaneous kidney biopsy for a small renal mass: a critical appraisal of results. J Urol 195:568–573
Delahunt B, Samaratunga H, Martignoni G, Srigley J, Evans A, Brunelli M (2014) Percutaneous renal tumour biopsy. Histopathology 65:295–308
Evans A, Delahunt B, Srigley J (2015) Issues and challenges associated with classifying neoplasms in percutaneous needle biopsies of incidentally found small renal masses. Semin Diagn Pathol 32:184–195
Williams BJ, Bottoms D, Treanor D (2017) Future-proofing pathology: the case for clinical adoption of digital pathology. J Clin Pathol 70:1010–1081
Mezheyeuski A, Hrynchyk I, Karlberg M, Portyanko A, Egevad L, Ragnhammar P et al (2016) Image analysis-derived metrics of histomorphological complexity predicts prognosis and treatment response in stage II–III colon cancer. Sci Rep 6:36149. https://doi.org/10.1038/srep36149
Jansen I, Lucas M, Savci-Heijink CD, Meijer SL, Marquering HA, de Bruin DM et al (2018) Histopathology: ditch the slides, because digital and 3D are on show. World J Urol 36:549–555
Raza Ali H, Dariush A, Provenzano E, Bardwell H, Abraham JE, Iddawela M et al (2016) Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer. Breast Cancer Res 18:21
Hamilton PW, Bankhead P, Wang Y, Hutchinson R, Kieran D, McArt DG et al (2014) Automated analysis for molecular profiling in lung cancer. Methods 70:59–73
Koelzer VH, Gisler A, Hanhart JC, Griss J, Wagner SN, Willi N et al (2018) Digital image analysis improves precision of programmed death ligand 1 (PD-L1) scoring in cutaneous melanoma. Histopathology https://doi.org/10.1111/his.13528 [Epub ahead of print]
Mroz P, Parwani A, Kulesza P (2013) Central pathology review for phase III clinical trials. The enabling effect of virtual microscopy. Arch Pathol Lab Med 137:492–495
Egevad L, Cheville J, Evans AJ, Hörnblad J, Kench JG, Kristiansen G et al (2017) Pathology imagebase—a reference image database for standardisation of pathology. Histopathology 71(5):677–685
Egevad L, Delahunt B, Berney DM, Bostwick DG, Cheville J, Comperat E et al (2018) Utility of pathology imagebase for standardisation of prostate cancer grading. Histopathology 7:8–18. https://doi.org/10.1111/his.13471 [Epub ahead of print]
Griffin J, Treanor D (2017) Digital pathology in clinical use: where are we now and what is holding us back? Histopathology 70:134–145
Cross S, Furness P, Igali L, Snead D, Treanor D (2018) Best practice recommendations for implementing digital pathology. The Royal College of Pathologists, London